Redwire Corporation Stock Price, News & Analysis

Redwire Corporation (NYSE: RDW), a leader in space and defense technology solutions, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. Chairman and CEO Peter Cannito will deliver a presentation on September 9, 2025, from 9:00 to 9:30 AM ET. The presentation will be accessible via webcast through a provided link.

Redwire Corporation (NYSE: RDW) has secured a significant $25 million IDIQ contract from NASA for a five-year period to provide biotechnology facilities and support services on the International Space Station (ISS). The contract includes an initial $2.5 million task order from NASA's InSPA program for drug development investigations using Redwire's PIL-BOX technology.

As the sole recipient, Redwire will manage and facilitate NASA-funded research investigations aboard the ISS, supporting life and materials sciences research. The company's expertise includes hundreds of successful microgravity experiments, partnerships with major pharmaceutical companies, and the recent formation of SpaceMD for orbital seed crystal growth to advance pharmaceutical development.

Redwire Corporation (NYSE: RDW), a leader in space and defense technology solutions, has announced that its Chairman and CEO Peter Cannito will deliver a presentation at the upcoming Jefferies Industrials Conference. The presentation is scheduled for September 3, 2025, from 4:10-4:45 p.m. ET. Investors and interested parties can access the presentation through a webcast link provided by the company.

Redwire (NYSE:RDW) has launched Acorn 2.0, an advanced AI-powered modeling and simulation software for aerospace and defense customers. Built on Modular Open System Architecture (MOSA), the software leverages agent-based modeling and artificial intelligence to simulate and validate complex space-based solutions.

The new version offers key capabilities including accelerated simulation modes, rapid integration testing, cyber vulnerability assessments, and compatibility with existing AI tools. Redwire has already begun deploying Acorn 2.0 to select customers, including DeepSat, an Earth observation startup that will use the software for satellite constellation optimization.

Redwire Corporation (NYSE: RDW) has secured a prototype phase agreement through its subsidiary Edge Autonomy to develop and deliver Stalker uncrewed aerial systems (UAS) for the U.S. Army's Long Range Reconnaissance (LRR) program. The Stalker UAS will be equipped with advanced sensors, secure communications, and autonomous mobility features for extended surveillance operations in contested environments.

The systems, designed with a Modular Open Systems Approach (MOSA), will provide Army units with real-time situational awareness and improved survivability in remote locations. Edge Autonomy, leveraging nearly three decades of technology heritage, will support the program with hands-on flight operations evaluation in the coming months.

Redwire Corporation (NYSE:RDW) reported Q2 2025 financial results, highlighting the transformative acquisition of Edge Autonomy completed on June 13, 2025. Q2 revenues decreased 20.9% to $61.8 million, with a net loss of $(97.0) million and Adjusted EBITDA of $(27.4) million.

Key developments include the Stalker drone system's addition to the DoD's Blue List and a U.S. Army prototype agreement. The company achieved a Book-to-Bill ratio of 1.47 and record total liquidity of $113.6 million. For FY2025, Redwire forecasts revenues of $385-445 million, or $470-530 million assuming Edge Autonomy integration from January 1, 2025.

Redwire (NYSE: RDW) has launched SpaceMD, a new venture focused on growing pharmaceutical seed crystals in space using their proven PIL-BOX technology. The company has already successfully crystallized 17 compounds on the ISS through 28 PIL-BOX system deployments.

SpaceMD has signed a groundbreaking licensing agreement with ExesaLibero Pharma to enhance their drug ELP-004, targeting bone erosion diseases. Under this first-of-its-kind agreement, SpaceMD will receive royalties from commercial sales of resulting pharmaceuticals. The collaboration aims to support ExesaLibero's FDA Investigative New Drug application and subsequent clinical trials.

Redwire currently operates eleven research and manufacturing facilities on the ISS, the largest presence of any company, and has previously partnered with major pharmaceutical companies like Bristol Myers Squibb and Eli Lilly.

Redwire Corporation (NYSE: RDW) has scheduled its second quarter 2025 financial results announcement for August 6, 2025, after market close. The company will host a conference call on August 7, 2025, at 9 a.m. EDT to discuss the quarterly results.

Investors can access the conference call via phone (toll-free: 877-485-3108 or toll: 201-689-8264) using conference ID 13755131. A live webcast with slides will be available on the company's investor relations website. For those unable to attend live, a replay will be accessible for two weeks following the event.

Redwire Corporation (NYSE: RDW) has secured the first phase of a multi-phase contract from DeepSat to provide digital engineering services for a Very Low Earth Orbit (VLEO) satellite constellation. The company will utilize its Acorn 2.0 Agent-Based Modeling and Simulation (ABMS) software to support the architectural design and optimization of DeepSat's constellation.

DeepSat's VLEO constellation aims to deliver real-time Earth intelligence with high revisit rates and in-orbit AI capabilities for various applications including vessel detection, energy infrastructure monitoring, and disaster assessment. The project leverages Redwire's Digitally Engineered Mission Systems & Integration (DEMSI) platform to accelerate development and reduce investor risk.